+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Beta Interferon - Global Strategic Business Report - Product Thumbnail Image

Beta Interferon - Global Strategic Business Report

  • Report
  • November 2025
  • 138 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 181 Pages
  • Global
From
Hydroxychloroquine - Global Strategic Business Report - Product Thumbnail Image

Hydroxychloroquine - Global Strategic Business Report

  • Report
  • November 2025
  • 293 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Thumbnail Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 282 Pages
  • Global
From
Autoimmune Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Disease Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 263 Pages
  • Global
From
Systemic Lupus Erythematosus Market - Global Forecast 2025-2032 - Product Thumbnail Image

Systemic Lupus Erythematosus Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 180 Pages
  • Global
From
Lodine Tincture Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lodine Tincture Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Celiac Disease Treatment Market Report 2025 - Product Thumbnail Image

Celiac Disease Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Hashimotos Disease Global Market Report 2025 - Product Thumbnail Image

Hashimotos Disease Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Corticosteroids Market Report 2025 - Product Thumbnail Image

Corticosteroids Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Gout Therapeutics Market Report 2025 - Product Thumbnail Image

Gout Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Glucosamine Gummies Market - Global Forecast to 2030 - Product Thumbnail Image

Glucosamine Gummies Market - Global Forecast to 2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Gout - Pipeline Insight, 2025 - Product Thumbnail Image

Gout - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Autoimmune Hepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Chronic Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Seborrhoeic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more